We then determined whether IL‐6 signaling was required for pMacs to limit the ability of UPEC to exploit extra‐macrophagic free iron by treating pMacs in the presence or absence of iron supplementation during the infection course, with a control antibody or anti‐IL‐6Rα added during infection. Here, IL6 is linked to infection.